LINETSKY DAVID (SVP, Life Sciences) sold 1.0% of their position (107.00 shares) of PHREESIA, INC. on the open market
Open‑market sale worth $1.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/19/2026ACC: 0001412408-26-000059
Officer· SVP, Life Sciences
Since Jul 2019
-107.00
Net shares
Net seller
$1.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
107.00 disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−107.00
Price / share
$11.06
Trade value
$1.18K
% of position
1.0%
3/18/2026
11.18K→11.07K
Total
Net shares
−107.00
Net value
-$1.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/18/2026 | S · Sale | −107.00 | $11.06 | $1.18K | 1.0% | 11.18K | 11.07K |
| Total | −107.00 | -$1.18K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned224.06K
Total
224.06K direct224.06K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 224.06K | Direct |
| Total | 224.06K | 224.06K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported